Prescription drug · NDA
Ultravate (Halobetasol propionate) NDC 73159-008
Halobetasol propionate .5 mg/g · Lotion · Topical · Lacer Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73159-008-60 | 73159000860 | 1 BOTTLE in 1 CARTON (73159-008-60) / 59 g in 1 BOTTLEMarketed from Apr 6, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ultravate
- Generic name (nonproprietary)
- halobetasol propionate
- Active ingredients
- Halobetasol propionate — .5 mg/g
- Dosage form
- Lotion
- Route
- Topical
- Labeler
- Lacer Pharma, LLCNDC labeler code 73159
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208183
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 73159-008_32225bd7-54bb-93da-e063-6394a90aadc5SPL ID 32225bd7-54bb-93da-e063-6394a90aadc5SPL set ID 74e899db-1c1f-48b2-9913-5d32a14906aeRxCUI 1789962, 1790329UNII 91A0K1TY3Z
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473159000860followed by a unit qualifier and the quantityPackage 73159-0008-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ULTRAVATE lotion is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ULTRAVATE lotion is a corticosteroid indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 73159-008
- What is NDC 73159-008?
- 73159-008 is the product NDC for Ultravate (halobetasol propionate), Halobetasol propionate .5 mg/g lotion, listed with the FDA by Lacer Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ultravate (Halobetasol propionate).
- What is the active ingredient?
- Halobetasol propionate.
- Who is the labeler?
- Lacer Pharma, LLC, NDC labeler code 73159. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ultravate?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 208183
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Halobetasol Propionate | Halobetasol propionate .5 mg/g | LotionTopical | Coral Way Pharma, LLC | 85437-008 |